Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG CLASS:

RIPK1 inhibitor

DRUG CLASS:

RIPK1 inhibitor

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Related drugs:

‹

›

BRAF V600E	Colorectal Cancer	BRAF V600E	Colorectal Cancer	TAK‐632 Sensitive: D – Preclinical TAK‐632 Sensitive : D	TAK‐632 Sensitive: D – Preclinical TAK‐632 Sensitive : D
BRAF V600E	Colorectal Cancer	BRAF V600E	Colorectal Cancer	PLX4720 + TAK‐632 Sensitive: D – Preclinical PLX4720 + TAK‐632 Sensitive : D	PLX4720 + TAK‐632 Sensitive: D – Preclinical PLX4720 + TAK‐632 Sensitive : D
BRAF V600E	Thyroid Gland Carcinoma	BRAF V600E	Thyroid Gland Carcinoma	TAK‐632 Sensitive: D – Preclinical TAK‐632 Sensitive : D	TAK‐632 Sensitive: D – Preclinical TAK‐632 Sensitive : D
ABCG2 overexpression	Colorectal Cancer	ABCG2 overexpression	Colorectal Cancer	GSK2606414 Sensitive: D – Preclinical GSK2606414 Sensitive : D	GSK2606414 Sensitive: D – Preclinical GSK2606414 Sensitive : D